Checkpoint Therapeutics I...

2.56
-0.30 (-10.49%)
At close: Mar 03, 2025, 3:59 PM
2.57
0.39%
After-hours: Mar 03, 2025, 07:08 PM EST

Checkpoint Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -51.85M -62.62M -56.67M -23.08M -24.71M -36.37M -22.68M -22.46M -13.89M
Depreciation & Amortization n/a n/a n/a n/a n/a n/a n/a 324K n/a
Stock-Based Compensation 2.9M 2.92M 3.14M 2.78M 3.12M 1.99M 3.12M 3.87M 3.25M
Other Working Capital 2.21M 14K 831K -935K 2.02M -716K -1.3M -656K 1.55M
Other Non-Cash Items 4.15M 6.75M 7.63M 5.52M 3.25M 2.56M 2.7M 7.42M 7.98M
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a -324K n/a
Change in Working Capital -2.79M -4.61M 19.6M -1.77M -3.03M 6M 1.4M 1.23M 1.55M
Operating Cash Flow -47.59M -57.55M -26.31M -16.55M -21.37M -25.8M -15.46M -9.95M -1.11M
Capital Expenditures n/a n/a n/a n/a n/a n/a -400K -3.16M -2.52M
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a -400K -3.16M -2.52M
Investing Cash Flow n/a n/a n/a n/a n/a n/a -400K -3.16M -2.52M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a -2.79M 2.55M
Common Stock Repurchased n/a -6K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 6.83M -2.73M -1.01M -2.02M -2.12M -2.42M n/a n/a n/a
Financial Cash Flow 40.45M 14.89M 40.27M 31.25M 25.45M 28.57M n/a -2.22M 54.05M
Net Cash Flow -7.14M -42.67M 13.96M 14.7M 4.08M 2.77M -15.86M -15.33M 54.05M
Free Cash Flow -47.59M -57.55M -26.31M -16.55M -21.37M -25.8M -15.86M -13.11M -3.63M